Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$14.05 - $23.44 $2.98 Million - $4.97 Million
211,917 Added 85.41%
460,044 $10.5 Million
Q3 2023

Nov 14, 2023

BUY
$16.68 - $23.66 $4.14 Million - $5.87 Million
248,127 New
248,127 $4.14 Million
Q4 2022

Feb 13, 2023

BUY
$7.36 - $11.17 $3.2 Million - $4.85 Million
434,635 New
434,635 $4.74 Million
Q4 2021

Feb 14, 2022

SELL
$17.63 - $37.1 $1.59 Million - $3.34 Million
-90,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$12.95 - $49.69 $1.17 Million - $4.47 Million
90,000 New
90,000 $1.6 Million

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.